Aytu BioPharma (AYTU) Stock Price, Quote, News & History | Benzinga

Aytu BioPharma Inc (AYTU) Stock Price, Quote, News & History

AYTUNASDAQ

Trade with Public

Trade with Public

$2.25

-0.05-2.17%

At close: May 13, 5:00 PM EST

$2.33

0.083.56%

After Hours: 5:44 PM EST

Earnings: Q3 2026 Earnings were released on Wed May 13th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 1 day ago

Click to view the webcast

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$2.30

Close

$2.25

Volume / Avg.

100.09K / 43.45K

Day Range

$2.23 - $2.31

52 Wk Range

1.26 - 3.07

Market Cap

$25.01M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

33

Short Interest

5.48%

Days to Cover

19.74

Recent Aytu Biopharma Inc News

Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard

Potential short squeeze plays gained steam in 2021, continued throughout 2022 and remained a focus of traders looking for the next big move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

Chris Katje

Aytu BioPharma Announces Strategic Shift, Indefinite Suspension of Clinical Development Programs

Vandana Singh

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-595.00K

Investing Cash Flow (TTM)

-3.10M

Financing Cash Flow (TTM)

13.33M

Free Cash Flow (TTM)

-3.70M

Capital Expenditure (TTM)

-3.10M

Net Change in Cash (TTM)

9.63M

Analyst Trends and Forecast

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$15.05M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.29

PB Ratio (TTM)

1.70

Earnings Yield % (TTM)

-152.89%

Earnings Yield % (FWD)

-16.22%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.32

Company Debt

Total Debt

$20.93M

LT Debt

$10.00M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.86M

Total Cash

$30.03M

Debt to Equity

1.47

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-$1.86M

Key Statistics

Open

$2.30

Close

$2.25

Volume / Avg.

100.09K / 43.45K

Day Range

$2.23 - $2.31

52 Wk Range

1.26 - 3.07

Market Cap

$25.01M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

33

Short Interest

5.48%

Days to Cover

19.74

About

Sector

Health Care

Industry

Pharmaceuticals

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other commo...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Aytu BioPharma (AYTU) stock?

A

You can purchase shares of Aytu BioPharma (NASDAQ:AYTU) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aytu BioPharma (AYTU) competitors?

A

There are no as such competitors for Aytu BioPharma.

Q

What is the forecast, or price target, for Aytu BioPharma (AYTU) stock?

A

Aytu BioPharma has a consensus price target of $12.00.

Q

What is the current price for Aytu BioPharma (AYTU)?

A

The stock price for Aytu BioPharma (NASDAQ: AYTU) is $2.33 last updated May 13, 2026 at 5:44 PM EDT.

Q

Does Aytu BioPharma (AYTU) pay a dividend?

A

There are no upcoming dividends for Aytu BioPharma.

Q

When is Aytu BioPharma (NASDAQ:AYTU) reporting earnings?

A

Aytu BioPharma does not have any upcoming earnings scheduled.

Q

Is Aytu BioPharma (AYTU) going to split?

A

There is no upcoming split for Aytu BioPharma.

Q

What sector and industry does Aytu BioPharma (AYTU) operate in?

A

Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.